A detailed history of Parkside Financial Bank & Trust transactions in Astrazeneca PLC stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 442 shares of AZN stock, worth $29,702. This represents 0.0% of its overall portfolio holdings.

Number of Shares
442
Previous 447 1.12%
Holding current value
$29,702
Previous $34,000 -0.0%
% of portfolio
0.0%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$76.67 - $87.62 $383 - $438
-5 Reduced 1.12%
442 $34,000
Q2 2024

Aug 05, 2024

BUY
$66.81 - $80.83 $2,672 - $3,233
40 Added 9.83%
447 $34,000
Q1 2024

May 01, 2024

BUY
$61.03 - $69.57 $19,651 - $22,401
322 Added 378.82%
407 $27,000
Q4 2023

Feb 01, 2024

BUY
$61.89 - $69.28 $5,260 - $5,888
85 New
85 $5,000
Q2 2023

Aug 15, 2023

BUY
$69.91 - $75.81 $1,607 - $1,743
23 New
23 $1,000
Q2 2022

Jul 13, 2022

SELL
$59.26 - $71.14 $23,585 - $28,313
-398 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$55.72 - $67.12 $21,730 - $26,176
390 Added 4875.0%
398 $26,000
Q4 2021

Feb 14, 2022

SELL
$54.02 - $63.83 $3,457 - $4,085
-64 Reduced 88.89%
8 $0
Q3 2021

Oct 29, 2021

BUY
$55.56 - $60.79 $4,000 - $4,376
72 New
72 $4,000
Q3 2018

Oct 12, 2018

SELL
$34.76 - $39.72 $258,927 - $295,874
-7,449 Closed
0 $0
Q2 2018

Aug 03, 2018

BUY
$34.55 - $37.05 $2,383 - $2,556
69 Added 0.93%
7,449 $262,000
Q1 2018

May 02, 2018

SELL
$32.97 - $36.63 $10,121 - $11,245
-307 Reduced 3.99%
7,380 $258,000
Q4 2017

Feb 05, 2018

BUY
$32.09 - $34.78 $7,380 - $7,999
230 Added 3.08%
7,687 $267,000
Q3 2017

Oct 27, 2017

BUY
$28.96 - $34.0 $215,954 - $253,538
7,457
7,457 $253,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $208B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Parkside Financial Bank & Trust Portfolio

Follow Parkside Financial Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Parkside Financial Bank & Trust with notifications on news.